FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024558300> ?p ?o ?g. }

• W2024558300 endingPage "1051" @default.
• W2024558300 startingPage "1045" @default.
• W2024558300 abstract "Orthotopic bladder reconstruction is the preferred method of urinary diversion following radical cystectomy (RC). Several papers reported functional data of different orthotopic neobladders, although to date, no one has used validated questionnaires. To evaluate the midterm functional results in a contemporary series of patients undergoing RC and vescica ileale Padovana (VIP) orthotopic neobladder by applying a set of validated questionnaires. We conducted a cross-sectional study at a single academic centre. We included RC and VIP orthotopic techniques for bladder transitional cell carcinoma. The American Urological Association Symptom Index (AUA-SI), the International Consultation on Incontinence Questionnaire–Urinary Incontinence Short Form (ICIQ-UI SF), and the five-item version of the International Index of Erectile Function (IIEF-5) were used to evaluate functional outcomes. All 113 patients who were alive and disease free at 44-mo follow-up were evaluated. Sixteen patients (13%) were on clean intermittent catheterisation (CIC). The median AUA-SI score of the 97 voiding patients was 9 (interquartile range [IQR]: 4.5–16). Specifically, 48.5%, 40.2%, and 11.3% of the patients had mild, moderate, or severe lower urinary tract symptoms (LUTS), respectively. American Society of Anaesthesiologists class (odds ratio [OR]: 9.0; p = 0.03) and body mass index (OR: 1.5; p = 0.023) were independent predictors of the need for CIC, while only patient age at the time of surgery (OR: 0.920; p = 0.01) was predictive of LUTS severity. The median ICIQ-UI SF score was 6 (IQR: 3–10). Twenty patients (17.7%) were fully continent, while 31.9%, 35.4%, and 15% had slight, moderate, and severe incontinence, respectively. About 90% of the patients during the day and 80% during the night used no pad or only a safety pad. Most of the patients leaked when asleep. No variable was predictive of return to continence. Finally, roughly 20% of the male patients were potent, having an IIEF-5 score ≥17. We reported midterm functional outcomes following RC and VIP neobladder using validated questionnaires. On the whole, the results are encouraging. However, in the absence of patient self-completed questionnaires, functional outcomes may be significantly overestimated." @default.
• W2024558300 created "2016-06-24" @default.
• W2024558300 creator A5011328299 @default.
• W2024558300 creator A5037164006 @default.
• W2024558300 creator A5047161343 @default.
• W2024558300 creator A5068041087 @default.
• W2024558300 creator A5083171847 @default.
• W2024558300 date "2010-06-01" @default.
• W2024558300 modified "2023-10-16" @default.
• W2024558300 title "Functional Results Following Vescica Ileale Padovana (VIP) Neobladder: Midterm Follow-up Analysis with Validated Questionnaires" @default.
• W2024558300 cites W167643697 @default.
• W2024558300 cites W1970134738 @default.
• W2024558300 cites W1983899242 @default.
• W2024558300 cites W1993190677 @default.
• W2024558300 cites W2028336830 @default.
• W2024558300 cites W2031694711 @default.
• W2024558300 cites W2050066055 @default.
• W2024558300 cites W2060139124 @default.
• W2024558300 cites W2061686105 @default.
• W2024558300 cites W2075164923 @default.
• W2024558300 cites W2075755438 @default.
• W2024558300 cites W2076668534 @default.
• W2024558300 cites W2077185461 @default.
• W2024558300 cites W2089456613 @default.
• W2024558300 cites W2103524234 @default.
• W2024558300 cites W2105021255 @default.
• W2024558300 cites W2111028094 @default.
• W2024558300 cites W2124678178 @default.
• W2024558300 cites W2136108195 @default.
• W2024558300 cites W2141009312 @default.
• W2024558300 cites W2154692607 @default.
• W2024558300 cites W2161271149 @default.
• W2024558300 cites W2170889433 @default.
• W2024558300 cites W2172082019 @default.
• W2024558300 cites W2288920846 @default.
• W2024558300 cites W2993539218 @default.
• W2024558300 cites W4211071658 @default.
• W2024558300 doi "https://doi.org/10.1016/j.eururo.2010.01.007" @default.
• W2024558300 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20096993" @default.
• W2024558300 hasPublicationYear "2010" @default.
• W2024558300 type Work @default.
• W2024558300 sameAs 2024558300 @default.
• W2024558300 citedByCount "52" @default.
• W2024558300 countsByYear W20245583002012 @default.
• W2024558300 countsByYear W20245583002013 @default.
• W2024558300 countsByYear W20245583002014 @default.
• W2024558300 countsByYear W20245583002015 @default.
• W2024558300 countsByYear W20245583002016 @default.
• W2024558300 countsByYear W20245583002017 @default.
• W2024558300 countsByYear W20245583002018 @default.
• W2024558300 countsByYear W20245583002019 @default.
• W2024558300 countsByYear W20245583002020 @default.
• W2024558300 countsByYear W20245583002021 @default.
• W2024558300 countsByYear W20245583002022 @default.
• W2024558300 countsByYear W20245583002023 @default.
• W2024558300 crossrefType "journal-article" @default.
• W2024558300 hasAuthorship W2024558300A5011328299 @default.
• W2024558300 hasAuthorship W2024558300A5037164006 @default.
• W2024558300 hasAuthorship W2024558300A5047161343 @default.
• W2024558300 hasAuthorship W2024558300A5068041087 @default.
• W2024558300 hasAuthorship W2024558300A5083171847 @default.
• W2024558300 hasConcept C119060515 @default.
• W2024558300 hasConcept C121608353 @default.
• W2024558300 hasConcept C126322002 @default.
• W2024558300 hasConcept C126894567 @default.
• W2024558300 hasConcept C141071460 @default.
• W2024558300 hasConcept C2775910329 @default.
• W2024558300 hasConcept C2776235491 @default.
• W2024558300 hasConcept C2777284795 @default.
• W2024558300 hasConcept C2779478474 @default.
• W2024558300 hasConcept C2780221984 @default.
• W2024558300 hasConcept C2780352672 @default.
• W2024558300 hasConcept C71924100 @default.
• W2024558300 hasConcept C77411442 @default.
• W2024558300 hasConceptScore W2024558300C119060515 @default.
• W2024558300 hasConceptScore W2024558300C121608353 @default.
• W2024558300 hasConceptScore W2024558300C126322002 @default.
• W2024558300 hasConceptScore W2024558300C126894567 @default.
• W2024558300 hasConceptScore W2024558300C141071460 @default.
• W2024558300 hasConceptScore W2024558300C2775910329 @default.
• W2024558300 hasConceptScore W2024558300C2776235491 @default.
• W2024558300 hasConceptScore W2024558300C2777284795 @default.
• W2024558300 hasConceptScore W2024558300C2779478474 @default.
• W2024558300 hasConceptScore W2024558300C2780221984 @default.
• W2024558300 hasConceptScore W2024558300C2780352672 @default.
• W2024558300 hasConceptScore W2024558300C71924100 @default.
• W2024558300 hasConceptScore W2024558300C77411442 @default.
• W2024558300 hasIssue "6" @default.
• W2024558300 hasLocation W20245583001 @default.
• W2024558300 hasLocation W20245583002 @default.
• W2024558300 hasOpenAccess W2024558300 @default.
• W2024558300 hasPrimaryLocation W20245583001 @default.
• W2024558300 hasRelatedWork W2044302646 @default.
• W2024558300 hasRelatedWork W2066626651 @default.
• W2024558300 hasRelatedWork W2108617753 @default.
• W2024558300 hasRelatedWork W2116980023 @default.
• W2024558300 hasRelatedWork W2165762581 @default.
• W2024558300 hasRelatedWork W2282988690 @default.

• next